Eleven early-stage companies working in oncology have started ‘Discovery Spark’, a free seven week development programme ...

Market OverviewThe digital health market is revolutionizing the healthcare sector by integrating cutting-edge technologies ...

EVERSANA®, a leading provider of commercialization services to the life science industry, today announced its strategic consulting arm, EVERSANA® CONSULTING, has again been recognized by Vault as a ...

PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology, today announces the first close of its ...

Bürkert Fluid Control Systems has taken a stake in Green Elephant Biotech as a strategic investor so the two companies can work together to develop more efficient, flexible and sustainable cell ...

Galapagos NV (Euronext & NASDAQ: GLPG), a global biotechnology company dedicated to transforming patient outcomes through life-changing science and innovation, today reported its financial results for ...

AQILION AB (publ) today announces that the company has divested its entire holding in Oncorena Holding AB. The decision is in line with Aqilion's strategy to focus the business to the internal ...

Cytovation ASA, a clinical stage oncology company focused on the development of its first-in-class bifunctional peptide CY-101, announces the appointment of Mr. Martin Dewhurst to its Board of ...

Genmab A/S (Nasdaq: GMAB) summons the Annual General Meeting on Wednesday, March 12, 2025, at 2:00 PM CET at the Copenhagen Marriott Hotel, Kalvebod Brygge 5, DK-1560 Copenhagen V, Denmark. The notice ...

Small cell lung cancer (SCLC) is one of the hardest types of cancer to treat and has often already spread by the time people are diagnosed. It mainly arises from neuroendocrine (NE) cells, which help ...

A scheduled review of the E.mbrace phase 3 study (clinical trial identifier: NCT04899336) conducted by an independent data monitoring committee (IDMC) determined that Sanofi and Johnson & Johnson’s ...

Alfa Chemistry has made a remarkable stride in the field of synthetic biology with the recent renewal of its oligonucleotide series products. This updated lineup includes a range of advanced ...